A Study of Mezagitamab in Adults With Late Antibody-Mediated Rejection (AMR) After a Kidney Transplant
Clinical trial NCT07613359 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07613359
- Sponsor
- Takeda
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-01
- Primary completion
- 2029-01-15
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.